Paxman AB (publ) (STO:PAX)
77.20
-2.20 (-2.77%)
Sep 2, 2025, 5:24 PM CET
Paxman AB Revenue
Paxman AB had revenue of 77.49M SEK in the quarter ending June 30, 2025, with 17.76% growth. This brings the company's revenue in the last twelve months to 283.78M, up 14.42% year-over-year. In the year 2024, Paxman AB had annual revenue of 263.20M with 19.30% growth.
Revenue (ttm)
283.78M
Revenue Growth
+14.42%
P/S Ratio
6.33
Revenue / Employee
2.03M
Employees
105
Market Cap
1.80B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 263.20M | 42.59M | 19.30% |
Dec 31, 2023 | 220.61M | 63.86M | 40.74% |
Dec 31, 2022 | 156.75M | 52.04M | 49.70% |
Dec 31, 2021 | 104.71M | 21.57M | 25.95% |
Dec 31, 2020 | 83.14M | -12.53M | -13.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB | 26.97B |
Sectra AB | 3.31B |
Getinge AB | 35.50B |
Camurus AB | 2.27B |
Medicover AB | 25.22B |
Asker Healthcare Group AB | 15.88B |
BioArctic AB | 1.86B |
AddLife AB | 10.44B |